Aadi Bioscience
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
17383 W Sunset Blvd Ste A250, Pacific Pa...Phone Number
(424) 744-8055Website
www.aadibio.comRevenue
$25.1 MillionStock Symbol
AADIIndustry
About Aadi Bioscience
AADI Bioscience is dedicated to improving the lives of individuals with mTOR-driven diseases through precision medicine and innovative albumin-bound nanoparticle technology. The company focuses on overcoming the limitations of existing mTOR inhibitors by utilizing advanced genomic profiling to identify patients who would benefit most from mTOR inhibition. Their product pipeline includes treatments for advanced malignant PEComa and they emphasize patient advocacy and expanded access initiatives. AADI Bioscience aims to serve healthcare professionals and patients seeking effective therapies for mTOR-related conditions.Explore more
Aadi Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aadi Bioscience
Compare insights from companies similar to Aadi Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aadi Bioscience Tech Stack
A closer look at the technologies used by Aadi Bioscience
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aadi Bioscience
Sign Up For FreeTo access detailed company insights
AADI Bioscience is dedicated to improving the lives of individuals with mTOR-driven diseases through precision medicine and innovative albumin-bound nanoparticle technology. The company focuses on overcoming the limitations of existing mTOR inhibitors by utilizing advanced genomic profiling to identify patients who would benefit most from mTOR inhi... Read More
